Category: Seminars

Dr. David W. Wood

Ohio State University

Chemical & Biomolecular Engineering

Friday-March 22, 2013

10:00 a.m.

 MUB-Alumni Lounge

New Technologies from Engineered Self-Modifying Proteins

Professor Wood’s work seeks to apply biological concepts of protein function, cell metabolism, genetics and evolution to the molecular-scale development of new technologies.  These goals are achieved through the development of designer fusion proteins that combine domains and functions from unrelated proteins and enzymes.  We typically combine rational protein engineering with genetic selection to create and fine-tune the desired activities.  In oseparations, we have combined a previously developed pH-sensitive self-cleaving protein with a variety of purification tags to produce simple and economical methods for purifying recombinant proteins.  Our most recent work involves rational and evolutionary approaches to optimizing our self-cleaving tags for use in a wider variety of expression hosts.  In biosensing, we have developed allosteric proteins that incorporate human hormone receptors, and have used these proteins to generate Escherichia coli strains that are growth-dependent on hormones and hormone-like compounds.  Remarkably, this genetically simple bacterial sensor can differentiate agonist from antagonist activities and has been effective in detecting a wide variety of strong and weak estrogenic compounds.  More recently, we have applied this system to the discovery of thyroid active compounds, as well as the evaluation of environmental endocrine disruptors in humans and animals, and even the discovery of possible autism-associated environmental factors.  Applications of our designed proteins are far-reaching, and include drug discovery, biosensing, drug activation, reversible knockouts for metabolic research, new genetic selection systems, and advanced cellular control strategies.

Dr. Todd M. Przybycien

 Carnegie Mellon University

Departments of Chemical Engineering and Biomedical Engineering 

Friday-February 22, 2013

10:00am

MUB- Alumni Lounge

Unconventional Applications of Poly(ethylene glycol)-modified Proteins in BioProcessing and Drug Delivery

The covalent attachment of poly(ethylene glycol) (PEG) polymer chains, or “PEGylation,” improves the efficacy of protein drugs by extending their half-lives in the circulation without adversely affecting biological binding activity: the PEG chains are thought to hinder recognition by proteases, inhibitors and antibodies through steric interactions and to retard renal clearance through increased molecular size.  We used a more complete understanding of the solution and interfacial adsorption behavior of PEG-protein conjugates to explore new applications of protein PEGylation in bioprocessing and drug delivery. 

We have developed new, high selectivity protein affinity chromatography media by PEGylating immobilized protein affinity ligands outside of the target binding site.  This discourages the non-specific binding of contaminant species without decreasing target binding.  We find selectivity enhancements for IgG-class antibodies of 2x to 3x for Protein A affinity chromatography media modified with 5 kDa and 20 kDa PEG chains relative to the un-modified media, without loss of antibody binding affinity.  Increased contaminant rejection by Protein A media has important implications for simplifying downstream processing operations for monoclonal antibody production and for extending the operating lifetime of this expensive class of bioseparations media.

We have exploited PEGylation to reduce denaturing adsorptive interactions between proteins and interfaces that limit the successful delivery of protein drugs from poly(lactide-co-glycolide) (PLG) microsphere delivery systems. Oil/water interfaces are present during the generation of protein-loaded PLG microspheres by the double emulsion technique and solid/water interfaces are present as the microspheres erode during delivery.  The depressed adsorption isotherms of conjugates reduce the extent of adsorption at denaturing interfaces and the attached PEG random coils serve as steric diluents at interfaces.  While PEGylation with 20 kDa PEG has little effect on protein behavior at ethyl acetate/water interfaces, at PLG/water interfaces we find decreased extents of adsorption, increased reversibility of adsorption and decreased tendency to aggregate.  These results have translated to ~50% and ~100% improvements in active protein release for monoPEGylated and diPEGylated ribonuclease A, respectively.

Dr. Thomas Werner, Assistant Professor

Michigan Technological University

Department of Biological Sciences

Friday-February 8, 2013

MUB Ballroom B at 10:00am

The role of toolkit genes in the evolution of complex wing, thorax, and abdominal color patterns in Drosophila guttifera.

Animal color patterns such as zebra stripes, leopard spots, and the myriad variants of butterfly wing color patterns are known to play important ecological and physiological roles in the life of animals and are crucial for the survival of species. Scientists first tried to solve the secret of animal patterns with mathematical approaches to find models that could explain how these patterns developed. In 1952, Turing proposed the famous reaction-diffusion model in which a short-range acting activator molecule diffuses from a source to stimulate color production, while a long-range acting inhibitor molecule prevents pigmentation. Using the spectacularly ornamented fruit fly Drosophila guttifera, we developed a transgenic protocol to study the development and evolution of color patterns. We identified that the Wingless morphogen had evolved a new function in the D. guttifera lineage by activating the yellow gene on pre-existing structural landmarks on the wing, causing black melanin spots around sensory organs, tips of the veins, and crossveins. We are currently expanding this work by investigating if the melanin patterns on different body parts of D. guttifera evolved by the same mechanisms involving Wingless, or if they have independently evolved

November 9: Dr. Megan C. Frost- Grain Processing Seminar Series in Chemical Engineering

Friday-November 9, 2012 at 10:00am

Fisher Hall, Room 139

Dr. Megan C. Frost, Assistant Professor

Department of Biomedical Engineering at Michigan Technological University

Topic: Developing Nitric Oxide Releasing Polymers and Test Platform to Understand  Cellular Response to Nitric Oxide

Polymeric materials used to coat or construct biomedical devices universally inspire a foreign body response when in contact with a biological system (e.g., thrombus formation on the polymer surface when in contact with blood, inflammatory response in subcutaneous tissue, etc.). Nitric oxide (NO) is a highly reactive free radical gas that has been shown to have a number positive of physiological functions at appropriate levels, including serving as a potent inhibitor of platelet adhesion and activation and mediating the inflammatory response. An NO-releasing silicone rubber coating was developed that contains a photosensitive S-nitrosothiol NO-donors that utilizes light as an external on/off trigger to initiate NO release. This material   shows dynamically controllable NO release based on the duration and intensity of light irradiating the material and offers  precise control of the level and duration of NO delivered at the tissue/polymer interface. We have also developed a test platform that allows quantitative levels of NO to be delivered to cells in vitro to further understanding of cellular response to NO.

April 5th: Chemical Engineering Grain Processing Corporation 2011-12 Graduate Lecture Series
Tarun K. Dam, Michigan Tech, Department of Chemistry;
Thursday, April 5, 2012, 1:00-2:00 P.M., Chem. Sci. & Engineering
Room 102

Topic: Glycan biding proteins in health and disease

More than half of the proteins in our body possess
covalently attached glycan or carbohydrate molecules. These
glycan molecules are recognized by a special group of proteins
known as glycan binding proteins (GBP) or lectins. Lectins play
important roles in numerous biological processes including
immune defense and pathogen invasion. Lectins interact with
their glycan ligands through a unique recognition process.
Specific examples of lectin-glycan interactions in cancer and
bio-detection and their clinical significance will be discussed.